The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability. (Q50863971)

24 March 2018

title

The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability. (English)

1 reference

24 March 2018

author

Gerhard H Braus

9

1 reference

24 March 2018

author name string

S Lüddecke

1

1 reference

24 March 2018

N Ertych

2

1 reference

24 March 2018

A Stenzinger

3

1 reference

24 March 2018

W Weichert

4

1 reference

24 March 2018

T Beissbarth

5

1 reference

24 March 2018

J Dyczkowski

6

1 reference

24 March 2018

J Gaedcke

7

1 reference

24 March 2018

O Valerius

8

1 reference

24 March 2018

M Kschischo

10

1 reference

24 March 2018

H Bastians

11

1 reference

24 March 2018

language of work or name

English

0 references

publication date

24 August 2015

1 reference

24 March 2018

published in

Oncogene

1 reference

24 March 2018

volume

35

1 reference

24 March 2018

issue

18

1 reference

24 March 2018

page(s)

2398-2406

1 reference

24 March 2018

https://scigraph.springernature.com/pub.10.1038/onc.2015.290

exact match

0 references

cites work

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Mechanisms of BRCA1 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Regulation of centrosomes by the BRCA1-dependent ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Network modeling links breast cancer susceptibility and centrosome dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

The centriolar satellite proteins Cep72 and Cep290 interact and are required for recruitment of BBS proteins to the cilium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Cep72 regulates the localization of key centrosomal proteins and proper bipolar spindle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Replication stress links structural and numerical cancer chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

XMAP215 is a processive microtubule polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Merotelic kinetochore attachment: causes and effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

The Chk2 tumor suppressor is not required for p53 responses in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Substrates of the BRCA1-dependent ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

BRCA1, a 'complex' protein involved in the maintenance of genomic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.290

Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26300001

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2015.290

1 reference

24 March 2018

PubMed ID

26300001

1 reference

24 March 2018